Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
New "machine learning" method helps analyze large amounts of biological data

New "machine learning" method helps analyze large amounts of biological data

UArizona researcher finds a unique approach to tackle both Alzheimer’s disease and diabetes

UArizona researcher finds a unique approach to tackle both Alzheimer’s disease and diabetes

Study shows persisting cognitive benefits of common Alzheimer’s treatment

Study shows persisting cognitive benefits of common Alzheimer’s treatment

Researchers are testing wearable devices to detect early Alzheimer's, other neurodegenerative diseases

Researchers are testing wearable devices to detect early Alzheimer's, other neurodegenerative diseases

Alzheimer’s symptoms linked to COVID-induced brain injury

Alzheimer’s symptoms linked to COVID-induced brain injury

Persistent loneliness during midlife can increase risk of dementia, Alzheimer’s disease

Persistent loneliness during midlife can increase risk of dementia, Alzheimer’s disease

Sargramostim drug can also improve memory in people with mild-to-moderate Alzheimer's disease

Sargramostim drug can also improve memory in people with mild-to-moderate Alzheimer's disease

Changes in OASI gene expression increases risk of Alzheimer's and severe COVID-19 infection

Changes in OASI gene expression increases risk of Alzheimer's and severe COVID-19 infection

‘Zombie’ cells come to life after the death of the brain

‘Zombie’ cells come to life after the death of the brain

Exercise increases blood flow to the brain, study shows

Exercise increases blood flow to the brain, study shows

Socioeconomic deprivation linked to large proportion of dementia deaths in England, Wales

Socioeconomic deprivation linked to large proportion of dementia deaths in England, Wales

Widening ideological gap in the U.S. may contribute to challenges in medical research

Widening ideological gap in the U.S. may contribute to challenges in medical research

Researchers test novel gene regulation approach to treat brain diseases

Researchers test novel gene regulation approach to treat brain diseases

Consumption of processed meat associated with increased risk of dementia

Consumption of processed meat associated with increased risk of dementia

Genetic engineering strategy dramatically reduces tau levels in Alzheimer's animal model

Genetic engineering strategy dramatically reduces tau levels in Alzheimer's animal model

Malfunctioning blood-brain barrier is linked to benign forgetfulness of aging

Malfunctioning blood-brain barrier is linked to benign forgetfulness of aging

New high-throughput system for testing drug candidates to treat brain diseases

New high-throughput system for testing drug candidates to treat brain diseases

New Alzheimer's model may help test novel treatments

New Alzheimer's model may help test novel treatments

UTSW researchers identify the structure of a key cell-surface protein

UTSW researchers identify the structure of a key cell-surface protein

Researchers find a better way to identify cells and understand the mechanisms of diseases

Researchers find a better way to identify cells and understand the mechanisms of diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.